Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$453K Sell
2,400
-1,400
-37% -$277K 0.76% 21
2021
Q4
$927K Buy
+3,800
New +$832K 0.69% 52

Other funds holding ZTS

Astrantus's ZTS Position: Q1 2022 in Review

Astrantus reduced its Zoetis (ZTS) stake by 37% in Q1 2022, selling an estimated $277K and leaving 2,400 shares worth $453K. The position accounts for 0.76% of the portfolio, ranked #21.

Astrantus first reported a position in ZTS in Q4 2021 and has held it in 2 quarters since. The position peaked at $927K in Q4 2021. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

  • Astrantus held 2,400 shares of Zoetis worth $453K as of Q1 2022.
  • Astrantus sold 1,400 Zoetis shares in Q1 2022, an estimated $277K.
  • Zoetis made up 0.76% of Astrantus's portfolio in Q1 2022, its #21 holding.
  • Astrantus first reported a position in Zoetis in Q4 2021 and has held it in 2 quarters since.
  • Astrantus's Zoetis position peaked at $927K in Q4 2021.
  • 1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.